Welcome to the upgraded MacSphere! We're putting the finishing touches on it; if you notice anything amiss, email macsphere@mcmaster.ca

CHARACTERIZATION OF ΔM51-VSV EXPRESSING BECLIN1

dc.contributor.advisorLichty, Brianen_US
dc.contributor.advisorBowdish, Dawnen_US
dc.contributor.advisorBowdish, Dawnen_US
dc.contributor.authorSmith, Elspeth K.en_US
dc.contributor.departmentMedical Sciencesen_US
dc.date.accessioned2014-06-18T16:54:27Z
dc.date.available2014-06-18T16:54:27Z
dc.date.created2011-09-28en_US
dc.date.issued2011-10en_US
dc.description.abstract<p>Autophagy is a cellular process in which cytoplasmic material is lysosomally degraded into its basic components. The primary functions of this process are cellular recycling and stress mitigation however it also has roles in both viral pathogenesis and tumourigenesis. Beclin1 is a key mediator of autophagy and is involved in its initiation. In an attempt to examine the effects of enhanced autophagy in the context of oncolytic VSV infection, a VSV mutant (ΔM51) expressing Beclin1 was constructed and characterized. It was determined through western blot analysis of autophagy marker LC3, that while VSV infection enhanced autophagy in infected cells, Beclin1 expression resulted in a transient increase in autophagy followed by markedly reduced levels of autophagy at mid to late time points. Still, Beclin1expression, either directly or possibly through altering the kinetics of VSV induced autophagy, enhanced the pathogenesis of VSV<em> </em>in some cell lines <em>in vitro</em>. However examination of the <em>in vivo</em> pathogenesis of VSV-Belcin1 elicited no differences from that of the parental virus. Despite enhanced pathogenesis in CT26 cells <em>in vitro</em>, VSV-Beclin1 displayed no improvement in the oncolysis of CT26 tumours <em>in vivo</em>, compared to VSV-GFP. It is hoped that the conclusions drawn from this study will help direct future research aimed at exploring the relationship between autophagy and VSV pathogenesis as well as future attempts to arm VSV with the intent of augmenting its oncolytic potential.</p>en_US
dc.description.degreeMaster of Science (MSc)en_US
dc.identifier.otheropendissertations/6348en_US
dc.identifier.other7379en_US
dc.identifier.other2262852en_US
dc.identifier.urihttp://hdl.handle.net/11375/11377
dc.subjectautophagy oncolytic viral pathogenesis apoptosis rapamycin VSVen_US
dc.subjectMedical Immunologyen_US
dc.subjectMedical Pathologyen_US
dc.subjectMedical Immunologyen_US
dc.titleCHARACTERIZATION OF ΔM51-VSV EXPRESSING BECLIN1en_US
dc.typethesisen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
fulltext.pdf
Size:
1.32 MB
Format:
Adobe Portable Document Format